Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreYour world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreFor government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MORENo life sciences organization has limitless promotion budgets – especially those preparing for their very first launch. When resources are constrained, you may be tempted to place greater bets on less costly digital channels. After all, the COVID-19 pandemic has further depressed in-person access to healthcare professionals (HCPs) and accelerated adoption of remote engagement.
But digital isn’t a panacea, and in-person promotion remains critically important. In fact, the return on face-to-face interactions can be at least two times higher than the impact realized through remote engagement. Further, some specialty areas are even more receptive to in-person promotion.
As you prepare for launch, you must tackle this challenging question: What’s the right combination of personal and non-personal promotion for each HCP – and how should I tweak that combination over time?